Blog

Blog

  • Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

  • Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

  • Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce that we are exhibiting at the 26th International Glycoconjugate Symposium (IGS) - Glyco26 in Taipei, Taiwan! Visit us...

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce that we are exhibiting at the 26th International Glycoconjugate Symposium (IGS) - Glyco26 in Taipei, Taiwan! Visit us...

1 of 3
  • Sussex Research Laboratories Inc. Welcomes Dr. Nycholat as New CSO and Director of U.S. Subsidiary in San Diego

    Sussex Research Laboratories Inc. Welcomes Dr. ...

    Sussex Research Laboratories Inc. (Sussex Research), a global leader in the translation of complex carbohydrate chemistries into unique, leading-edge products and services that enable researchers to explore and exploit glycomics...

    Sussex Research Laboratories Inc. Welcomes Dr. ...

    Sussex Research Laboratories Inc. (Sussex Research), a global leader in the translation of complex carbohydrate chemistries into unique, leading-edge products and services that enable researchers to explore and exploit glycomics...

  • Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board

    Sussex Research Laboratories Inc. Appoints Dr. ...

    Sussex Research Laboratories Inc. (Sussex Research), a global leader in carbohydrate synthesis and the translation of complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit...

    Sussex Research Laboratories Inc. Appoints Dr. ...

    Sussex Research Laboratories Inc. (Sussex Research), a global leader in carbohydrate synthesis and the translation of complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit...

  • Sussex Research Laboratories Inc. / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19

    Sussex Research Laboratories Inc. / Queen’s Uni...

    Sussex Research Laboratories Inc. (Ottawa, Canada) today announced that Queen’s University and the Southeastern Ontario Academic Medical Organization (SEAMO) has awarded grants for two COVID-19 Rapid Response collaborations between Queen’s...

    Sussex Research Laboratories Inc. / Queen’s Uni...

    Sussex Research Laboratories Inc. (Ottawa, Canada) today announced that Queen’s University and the Southeastern Ontario Academic Medical Organization (SEAMO) has awarded grants for two COVID-19 Rapid Response collaborations between Queen’s...

1 of 3